X Bioscience PCL (BKK:XBIO)
Thailand
· Delayed Price · Currency is THB 0.1800
+0.0100 (5.88%)
At close: Jun 5, 2025, 4:30 PM ICT
X Bioscience PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -275.68 | -260.22 | -147.52 | -575.99 | -276.45 | -238.81 | Upgrade
|
| Depreciation & Amortization | 77.44 | 65.35 | 46.04 | 143.95 | 118.78 | 91.26 | Upgrade
|
| Other Amortization | 1.94 | 1.94 | 0.57 | 2.27 | 1.28 | 0.57 | Upgrade
|
| Loss (Gain) From Sale of Assets | 21.35 | -0.3 | 0 | 98.28 | 0.26 | 119.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 100.25 | 100.21 | 25.06 | 86.78 | 4.52 | -19.37 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.04 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.99 | 6.99 | - | - | - | -3.07 | Upgrade
|
| Other Operating Activities | -25.13 | -11.03 | 8.22 | 10.3 | 190.49 | 24.68 | Upgrade
|
| Change in Accounts Receivable | 5.58 | 21.17 | -3.12 | -9.72 | -10.28 | 2.84 | Upgrade
|
| Change in Inventory | -4.88 | -4.5 | 6.33 | -6.61 | -14.88 | -24.07 | Upgrade
|
| Change in Accounts Payable | 38.31 | 38.31 | -3.82 | 100.5 | 35.27 | 19.75 | Upgrade
|
| Change in Other Net Operating Assets | 3.31 | 4.64 | -8.06 | -2.16 | -11.58 | -2.91 | Upgrade
|
| Operating Cash Flow | -50.52 | -37.44 | -76.31 | -152.41 | -139.13 | -30.11 | Upgrade
|
| Capital Expenditures | -28.19 | -36.33 | -57.28 | -138.81 | -73.43 | -37.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.98 | 2.11 | 4.1 | 3.51 | 0.06 | 0.26 | Upgrade
|
| Cash Acquisitions | -445.01 | -445.01 | - | - | - | -314.52 | Upgrade
|
| Divestitures | - | - | - | 267.06 | - | 61.82 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 10 | Upgrade
|
| Other Investing Activities | -0.25 | -0.25 | - | -0.2 | -0.6 | -0.22 | Upgrade
|
| Investing Cash Flow | -471.47 | -479.47 | -53.18 | 131.56 | -73.97 | -345.97 | Upgrade
|
| Short-Term Debt Issued | - | 28.06 | 260.5 | 517.45 | 294.59 | 144.49 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 6 | 10.55 | Upgrade
|
| Total Debt Issued | 24.44 | 28.06 | 260.5 | 517.45 | 300.59 | 155.04 | Upgrade
|
| Short-Term Debt Repaid | - | -76.9 | -311.26 | -456.22 | -66.49 | -99.87 | Upgrade
|
| Long-Term Debt Repaid | - | -42.64 | -36.93 | -59.14 | -36.49 | -15.5 | Upgrade
|
| Total Debt Repaid | -139.33 | -119.54 | -348.19 | -515.36 | -102.97 | -115.36 | Upgrade
|
| Net Debt Issued (Repaid) | -114.89 | -91.48 | -87.69 | 2.09 | 197.61 | 39.68 | Upgrade
|
| Issuance of Common Stock | 635.2 | 590.84 | 227.78 | - | 0 | 338.09 | Upgrade
|
| Other Financing Activities | -0.63 | - | - | 6.9 | - | - | Upgrade
|
| Financing Cash Flow | 519.67 | 499.36 | 140.09 | 8.99 | 197.61 | 377.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.36 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0.09 | - | Upgrade
|
| Net Cash Flow | -2.32 | -17.56 | 10.59 | -11.86 | -15.4 | 2.04 | Upgrade
|
| Free Cash Flow | -78.71 | -73.77 | -133.59 | -291.22 | -212.57 | -67.58 | Upgrade
|
| Free Cash Flow Margin | -25.74% | -23.11% | -42.85% | -84.54% | -83.67% | -16.26% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.06 | -0.15 | -0.36 | -0.26 | -0.10 | Upgrade
|
| Cash Interest Paid | 20.41 | 18.99 | 30.47 | 48.17 | 3.55 | 1.74 | Upgrade
|
| Levered Free Cash Flow | -154.47 | -148.08 | -99.45 | -202.98 | -1.21 | 234.37 | Upgrade
|
| Unlevered Free Cash Flow | -134.92 | -126.65 | -74.48 | -167.66 | 7.82 | 244.73 | Upgrade
|
| Change in Net Working Capital | 10.51 | 0.61 | -11.46 | -1.96 | -24.04 | -272.64 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.